Redefining kidney disease: Clinico-pathological and molecular findings from the Kidney Precision Medicine Project
Limonte, C. P.; Schaub, J. A.; Fallegger, R.; Menon, R.; Schmidt, I. M.; de Boer, I. H.; Parikh, C.; Alpers, C. E.; Caramori, M. L.; Rosas, S.; Mottl, A.; Brosius, F.; Tuttle, K.; Lash, J.; Saez-Rodriguez, J.; Mariani, L. H.; Ricardo, A. C.; Eadon, M. T.; Ju, W.; Henderson, J.; Barisoni, L.; Hodgin, J. B.; Zelnick, L. R.; Sharma, K.; Spraggins, J.; Srivastava, A.; Schrauben, S.; Weir, M.; Hsu, C.-y.; Kelly, T.; Taliercio, J.; Rincon-Choles, H.; Dubin, R.; Cohen, D. L.; Xie, D.; Chen, J.; He, J.; Anderson, A. H.; Kretzler, M.; Himmelfarb, J.; And the CRIC Study Investigators, ; And the Kidney
Show abstract
BackgroundThe Kidney Precision Medicine Project (KPMP) consortium aims to redefine chronic kidney disease (CKD) by integrating clinical, pathological, and molecular tissue data from kidney biopsies. Here, we demonstrate how biopsy data in CKD can clarify disease etiology and contribute to understandings of disease pathophysiology and clinical prognosis. MethodsThe KPMP is obtaining research kidney biopsies from individuals with CKD (defined as an estimated glomerular filtration rate [eGFR] < 60 mL/min/1.73m2 and/or albuminuria [≥]30 mg/g creatinine) and diabetes (enrolled as diabetes and CKD or DKD) or hypertension (enrolled as hypertension and CKD or HCKD). A team of kidney pathologists and nephrologists adjudicated the primary clinico-pathological diagnosis for 258 participants with CKD. We compared pathological features and kidney transcriptional signatures between participants with a primary adjudicated diagnosis of diabetic nephropathy and those with other causes of CKD. We developed a model using clinical and biomarker data that predicted the probability of diabetic nephropathy and tested associations of the signature with CKD progression among Chronic Renal Insufficiency Cohort (CRIC) participants with diabetes (n=229). ResultsAmong 183 participants enrolled as DKD, 102 (56%) had a primary adjudicated clinico-pathologic diagnosis of diabetic nephropathy. Among 75 participants enrolled as HCKD, 42 (56%) had a primary diagnosis of hypertension-associated kidney disease. Those with diabetic nephropathy, compared with other diagnoses, had more severe interstitial fibrosis, tubular atrophy, tubular injury, segmental sclerosis, and severe arteriolar hyalinosis, and single-nucleus and single-cell transcriptional analyses revealed upregulation of immune and inflammatory pathways and downregulation of oxidative phosphorylation. A combination of age, hemoglobin A1c, urine albumin-creatinine ratio, and serum KIM-1 and sTNFR1 predicted a clinico-pathologic diagnosis of diabetic nephropathy in the KPMP (AUC 0.82, 95% CI 0.75-0.89) and was associated with an increased risk of CKD progression among patients with diabetes enrolled in CRIC (HR 1.48 [95% CI 1.27-1.73] per 10% higher predicted probability of diabetic nephropathy). ConclusionIn common presentations of CKD, kidney biopsies may alter a priori impressions, reveal a diversity of diagnosis, structure, and function that is associated with clinical outcomes and can impact therapeutic decisions.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.